{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:22:54Z","timestamp":1763036574362,"version":"3.44.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.annder.2011.01.016","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T04:56:30Z","timestamp":1298436990000},"page":"182-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pemphigus\u00a0: revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"138","author":[{"given":"P.","family":"Joly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2011.01.016_bib0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0030-4220(74)90365-X","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.annder.2011.01.016_bib0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","article-title":"Pemphigus: analysis of 1209\u00a0cases","volume":"44","author":"Chams-Davatchi","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-195302000-00001","article-title":"Pemphigus","volume":"32","author":"Lever","year":"1953","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2011.01.016_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaut.2005.03.006","article-title":"Genetic factors in pemphigus","volume":"24","author":"Tron","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.annder.2011.01.016_bib0025","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI28547","article-title":"T cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2011.01.016_bib0030","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"1","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2011.01.016_bib0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1067\/mjd.2001.112225","article-title":"Laryngeal and nasal involvement in pemphigus vulgaris","volume":"44","author":"Hale","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D34X05D6VH","article-title":"Nail disease in pemphigus vulgaris","volume":"15","author":"Serratos","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2011.01.016_bib0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0733-8635(18)30241-9","article-title":"Pemphigus vulgaris and vegetans","volume":"11","author":"Becker","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2011.01.016_bib0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-3083.1999.tb00826.x","article-title":"Herpetiform pemphigus","volume":"12","author":"Dias","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0060","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00510366","article-title":"Induced pemphigus","volume":"274","author":"Ruocco","year":"1982","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2011.01.016_bib0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archderm.1979.04010040006002","article-title":"Correlation of antibodies in skin and serum with disease severity in pemphigus","volume":"115","author":"Judd","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0085","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1067\/mjd.2003.438","article-title":"Antibodies to desmoglein 1\u00a0and 3, and the clinical phenotype of pemphigus vulgaris","volume":"48","author":"Jamora","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1\u00a0and 3\u00a0antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1\u00a0and 3\u00a0for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"Elisa testing of anti-desmoglein 1\u00a0and 3\u00a0antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0105","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00403-008-0901-y","article-title":"Detection of anti-envoplakin and anti-periplakin autoantibodies by Elisa in patients with paraneoplastic pemphigus","volume":"301","author":"Huang","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2011.01.016_bib0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.07.021","article-title":"Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay","volume":"129","author":"Mouquet","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.annder.2011.01.016_bib0115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy of pemphigus","volume":"120","author":"Bystryn","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus: a 20-year review of 107\u00a0patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0125","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief high-dose intravenous glucocorticoids","volume":"132","author":"Werth","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1468-3083.2002.00413.x","article-title":"Dexamethasone pulse therapy in pemphigus","volume":"16","author":"Toth","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","article-title":"The adjuvant therapy of pemphigus. An update","volume":"132","author":"Bystryn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0145","first-page":"224","article-title":"Anti-B-cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus: an update","volume":"15","author":"Arin","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0150","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0190-9622(03)02738-5","article-title":"Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris","volume":"49","author":"Mimouni","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2011.01.016_bib0175","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2230.1981.tb02338.x","article-title":"Correlation of circulating intercellular antibody titres in pemphigus with disease activity","volume":"6","author":"Creswell","year":"1981","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0180","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.1957.02980280023007","article-title":"Treatment of pemphigus with corticosteroids; study of fifty-two patients","volume":"165","author":"Costello","year":"1957","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.annder.2011.01.016_bib0185","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archderm.1963.01590130018006","article-title":"Treatment of pemphigus with corticosteroids. Results obtained in 46\u00a0patients over a period of 11years","volume":"87","author":"Lever","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0190-9622(96)80066-1","article-title":"Influence of treatment on the clinical course of pemphigus vulgaris","volume":"34","author":"Carson","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0195","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archderm.136.7.868","article-title":"Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus","volume":"136","author":"Ioannides","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archderm.1984.01650370050009","article-title":"Treatment of pemphigus vulgaris. Results obtained in 84\u00a0patients between 1961\u00a0and 1982","volume":"120","author":"Lever","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-4362.1990.tb04765.x","article-title":"Pemphigus therapy with oral prednisolone regimens. A 5-year study","volume":"29","author":"Ratnam","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0210","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archderm.1977.01640090084013","article-title":"Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63\u00a0patients between 1961\u00a0and 1975","volume":"113","author":"Lever","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0215","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-4362.1988.tb02409.x","article-title":"The course and prognosis of pemphigus. A review of 115\u00a0patients","volume":"27","author":"Seidenbaum","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1346-8138.1978.tb01047.x","article-title":"Pemphigus: a survey of 85\u00a0patients between 1970\u00a0and 1974","volume":"5","author":"Hirone","year":"1978","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0036-46652001000100007","article-title":"Treatment of pemphigus vulgaris and pemphigus foliaceus: experience with 71\u00a0patients over a 20-year period","volume":"43","author":"Fernandes","year":"2001","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.annder.2011.01.016_bib0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/archderm.1988.01670020054017","article-title":"Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine","volume":"124","author":"Fine","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17843286.1990.11718059","article-title":"D-penicillamine induced pemphigus treated with methylprednisolone pulse therapy","volume":"45","author":"Wouters","year":"1990","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.annder.2011.01.016_bib0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-4362.1995.tb04450.x","article-title":"Steroid-pulse therapy in pemphigus vulgaris long term follow-up","volume":"34","author":"Chryssomallis","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1600-0714.2002.00085.x","article-title":"High-dose intravenous \u2018pulse\u2019 methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study","volume":"31","author":"Mignogna","year":"2002","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0250","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archderm.142.5.570","article-title":"Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial","volume":"142","author":"Mentink","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1468-3083.2002.00461.x","article-title":"Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols","volume":"16","author":"Femiano","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0260","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/archderm.1996.03890360091015","article-title":"Pulse glucocorticoid therapy. The \u2018big shot\u2019 revisited","volume":"132","author":"Roujeau","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archderm.1960.01580030079010","article-title":"Dermatitis herpetiformis with acantholysis or pemphigus with response to sulfonamides: report of two cases","volume":"82","author":"Winkelmann","year":"1960","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0270","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2133.1976.tb05168.x","article-title":"Pemphigus controlled by dapsone","volume":"94","author":"Piamphongsant","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-4362.1981.tb00414.x","article-title":"When and how to use sulfones in bullous diseases","volume":"20","author":"Jablonska","year":"1981","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/09546630600921197","article-title":"Pemphigus foliaceus induced by radiotherapy and responsive to dapsone","volume":"17","author":"Cianchini","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2011.01.016_bib0285","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.1987.01660300105021","article-title":"Dapsone as initial treatment in superficial pemphigus. Report of nine cases","volume":"123","author":"Basset","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.1976.tb01409.x","article-title":"Eosinophilic spongiosis: a clinical histological and immunofluorescent correlation","volume":"1","author":"Knight","year":"1976","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archderm.1980.01640250067019","article-title":"Pemphigus vegetans: its relationship to eosinophilic spongiosis and favorable response to dapsone","volume":"116","author":"Pearson","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0300","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000250907","article-title":"Dapsone in the treatment of pemphigus vulgaris","volume":"156","author":"Haim","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.annder.2011.01.016_bib0305","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2230.2008.02881.x","article-title":"A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996\u20132006)","volume":"33","author":"Ishii","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0310","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archderm.141.6.699","article-title":"Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"141","author":"Heaphy","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0320","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0190-9622(08)80651-2","article-title":"Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13\u00a0cases","volume":"28","author":"Chaffins","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0325","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archderm.1995.01690230121025","article-title":"Is the combination of tetracycline and nicotinamide therapy alone effective in pemphigus?","volume":"131","author":"Alpsoy","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-0960.1996.tb01013.x","article-title":"Minocycline is a useful adjuvant therapy for pemphigus","volume":"37","author":"Gaspar","year":"1996","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0335","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archderm.136.9.1133","article-title":"Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid","volume":"136","author":"Ozog","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-4362.1999.00624.x","article-title":"Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients","volume":"38","author":"Calebotta","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0345","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000249367","article-title":"Oral gold therapy (Auranofin) in pemphigus vulgaris","volume":"172","author":"Salomon","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.annder.2011.01.016_bib0350","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archderm.134.9.1104","article-title":"Treatment of pemphigus with gold","volume":"134","author":"Pandya","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0355","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archderm.1973.01620240070024","article-title":"Azathioprine and pemphigus vulgaris","volume":"108","author":"Burton","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0360","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0365","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.1973.01620180007002","article-title":"Pemphigus treatment with azathioprine. Clinical and immunologic correlation","volume":"107","author":"Roenigk","year":"1973","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0375","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0380","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-3083.2007.02286.x","article-title":"An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study","volume":"21","author":"Chaidemenos","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0385","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archderm.1972.01620140005001","article-title":"Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid","volume":"106","author":"Krain","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0390","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.1975.tb02251.x","article-title":"Treatment of pemphigus with cyclophosphamide","volume":"93","author":"Pasricha","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0395","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.1978.01640180023005","article-title":"Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris","volume":"114","author":"Fellner","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0400","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1346-8138.1979.tb01927.x","article-title":"Treatment of pemphigus with corticosteroids and cyclophosphamide","volume":"6","author":"Piamphongsant","year":"1979","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0405","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-4362.1994.tb01003.x","article-title":"Treatment of oral pemphigus vulgaris","volume":"33","author":"Chrysomallis","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0410","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0190-9622(87)70226-6","article-title":"Use of cyclophosphamide in azathioprine failures in pemphigus","volume":"17","author":"Ahmed","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0415","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4362.1995.tb04430.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy for pemphigus","volume":"34","author":"Pasricha","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0420","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2133.1988.tb07104.x","article-title":"Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus","volume":"119","author":"Pasricha","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0425","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4362.1992.tb03549.x","article-title":"Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris","volume":"31","author":"Pasricha","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0430","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-4362.1990.tb04767.x","article-title":"Dexamethasone-cyclophosphamide pulse therapy in pemphigus","volume":"29","author":"Kaur","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0435","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000057886","article-title":"Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus","volume":"204","author":"Kanwar","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2011.01.016_bib0440","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1610-0378.2005.04747.x","article-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study","volume":"3","author":"Rose","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2011.01.016_bib0445","first-page":"1","article-title":"Pulse versus oral methylprednisolone therapy in pemphigus vulgaris","volume":"10","author":"Shahidi-Dadras","year":"2007","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0450","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archderm.135.1.57","article-title":"Pulse intravenous cyclophosphamide therapy in pemphigus","volume":"135","author":"Fleischli","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0455","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/0378-6323.55390","article-title":"Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris","volume":"75","author":"Sethy","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"doi-asserted-by":"crossref","unstructured":"Saha M, Powell AM, Bhogal B, Black MM, Groves RW. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus. Br J Dermatol 2009.","key":"10.1016\/j.annder.2011.01.016_bib0460","DOI":"10.1111\/j.1365-2133.2009.09590.x"},{"key":"10.1016\/j.annder.2011.01.016_bib0465","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0190-9622(08)81506-X","article-title":"The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study","volume":"30","author":"Lapidoth","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0470","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0190-9622(88)70132-2","article-title":"Treatment of nine cases of pemphigus vulgaris with cyclosporine","volume":"18","author":"Barthelemy","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0475","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0190-9622(90)70277-O","article-title":"Prolonged remission after cyclosporine therapy in pemphigus vulgaris: report of two young siblings","volume":"23","author":"Alijotas","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0480","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.135.1.54","article-title":"Mycophenolate is effective in the treatment of pemphigus vulgaris","volume":"135","author":"Enk","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0485","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archderm.135.6.724","article-title":"Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy","volume":"135","author":"Grundmann-Kollmann","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0490","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2133.2003.05269.x","article-title":"An evaluation of the usefulness of mycophenolate mofetil in pemphigus","volume":"149","author":"Powell","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0495","first-page":"23","article-title":"Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris","volume":"129","author":"Chams-Davatchi","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0500","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1970.tb15707.x","article-title":"Immunosuppressants in the treatment of pemphigus","volume":"83","author":"Jablonska","year":"1970","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0505","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archderm.1972.01620130023006","article-title":"Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36\u00a0patients between 1961\u00a0and 1970","volume":"106","author":"Lever","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0510","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-4362.1973.tb00016.x","article-title":"Use of methotrexate to treat pemphigus foliaceus","volume":"12","author":"Rivitti","year":"1973","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0515","first-page":"171","article-title":"Pemphigus: combined treatment with methotrexate and prednisone","volume":"58","author":"Piamphongsant","year":"1975","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.annder.2011.01.016_bib0520","first-page":"413","article-title":"Mucous membrane manifestations of pemphigus vulgaris. A 25-year survey of 185\u00a0patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin","volume":"68","author":"Mashkilleyson","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0525","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archderm.135.10.1275","article-title":"Methotrexate as an adjuvant treatment for pemphigus vulgaris","volume":"135","author":"Smith","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0530","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2133.2009.09246.x","article-title":"Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid","volume":"161","author":"Gurcan","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0535","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1365-2133.1998.02297.x","article-title":"Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy?","volume":"138","author":"Colonna","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0540","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1365-2133.1999.02817.x","article-title":"High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14\u00a0cases","volume":"140","author":"Harman","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0545","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jaad.2008.01.007","article-title":"Intravenous immunoglobulin selectively decreases circulating autoantibodies in pemphigus","volume":"58","author":"Czernik","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0550","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archdermatol.2008.503","article-title":"Effect of intravenous immunoglobulin therapy on serum levels of IgG1\u00a0and IgG4\u00a0antidesmoglein 1\u00a0and antidesmoglein 3\u00a0antibodies in pemphigus vulgaris","volume":"144","author":"Green","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0555","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0190-9622(89)80148-3","article-title":"High-dosage intravenous gamma globulin: therapeutic failure in pemphigus and pemphigoid","volume":"20","author":"Tappeiner","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0560","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(08)80783-9","article-title":"Effects of intravenous gamma-globulin in pemphigus","volume":"22","author":"Humbert","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0565","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1365-2133.1995.tb06952.x","article-title":"High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris","volume":"133","author":"Messer","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0570","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.1995.tb02631.x","article-title":"Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients","volume":"133","author":"Beckers","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0575","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2133.1996.d01-949.x","article-title":"Successful treatment of pemphigus vulgaris by pulsed intravenous immunoglobulin therapy","volume":"135","author":"Bewley","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0580","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2133.1996.tb03913.x","article-title":"Successful treatment of refractory mucosal lesions of pemphigus vulgaris using intravenous gammaglobulin as adjuvant therapy","volume":"135","author":"Wever","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0585","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0190-9622(99)70516-5","article-title":"Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris","volume":"40","author":"Jolles","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0590","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/mjd.2000.108366","article-title":"Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris","volume":"43","author":"Engineer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0595","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1067\/mjd.2001.116339","article-title":"Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment","volume":"45","author":"Ahmed","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0600","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archderm.138.9.1158","article-title":"Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris","volume":"138","author":"Sami","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0605","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1067\/mjd.2002.122735","article-title":"Treatment of pemphigus with intravenous immunoglobulin","volume":"47","author":"Bystryn","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0610","first-page":"48","article-title":"Serum levels of autoantibodies to desmoglein 3\u00a0in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins","volume":"84","author":"Herzog","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2011.01.016_bib0615","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mjd.2002.116338","article-title":"Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy","volume":"46","author":"Ahmed","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0620","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1999.03071.x","article-title":"Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins","volume":"141","author":"Toth","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0625","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0630","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/archderm.1988.01670110062013","article-title":"Plasmapheresis therapy of pemphigus","volume":"124","author":"Bystryn","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0635","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.1983.01650270033013","article-title":"Plasma exchange in pemphigus. Uncontrolled study of ten patients","volume":"119","author":"Roujeau","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0640","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0190-9622(90)70004-2","article-title":"Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies","volume":"22","author":"Tan-Lim","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0645","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archderm.1979.04010060036025","article-title":"Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris","volume":"115","author":"Auerbach","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0650","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2133.1982.tb00909.x","article-title":"Plasma exchange in corticosteroid-resistant pemphigus","volume":"106","author":"Roujeau","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0655","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000249707","article-title":"Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus","volume":"168","author":"Ruocco","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.annder.2011.01.016_bib0660","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mjd.2000.109297","article-title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","volume":"43","author":"Turner","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0665","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0670","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-112-4-303","article-title":"Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris","volume":"112","author":"Rook","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0675","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0190-9622(08)80560-9","article-title":"Pemphigus vulgaris treated with photopheresis","volume":"26","author":"Liang","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0680","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0190-9622(08)80854-7","article-title":"Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis","volume":"28","author":"Gollnick","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0685","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000018090","article-title":"Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases","volume":"198","author":"Wollina","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2011.01.016_bib0690","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1517\/13543784.9.9.2017","article-title":"Immunoadsorption, current status and future developments","volume":"9","author":"Braun","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.annder.2011.01.016_bib0695","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1365-2133.2003.05302.x","article-title":"Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus","volume":"148","author":"Schmidt","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0700","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","article-title":"Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy","volume":"48","author":"Silverman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2011.01.016_bib0705","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.annder.2011.01.016_bib0710","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archderm.140.1.91","article-title":"Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20\u00a0monoclonal antibody)","volume":"140","author":"Dupuy","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0715","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20\u00a0antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0720","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2133.2005.06651.x","article-title":"Anti-CD20\u00a0monoclonal antibody (rituximab) in the treatment of pemphigus","volume":"153","author":"Arin","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0725","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annder.2011.01.016_bib0730","first-page":"269","article-title":"Anti-CD20\u00a0monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0735","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMcpc030016","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions","volume":"349","author":"Ahmed","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2011.01.016_bib0740","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1365-2133.1999.02895.x","article-title":"The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid","volume":"140","author":"Dumas","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2011.01.016_bib0745","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/0030-4220(94)90318-2","article-title":"Double-blind clinical trial of 0.05\u00a0% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05\u00a0% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases","volume":"77","author":"Lozada-Nur","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.annder.2011.01.016_bib0750","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-3083.2006.01873.x","article-title":"Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial","volume":"21","author":"Tabrizi","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963811000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:58:28Z","timestamp":1758970708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963811000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":150,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0151963811000445"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.016","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemphigus\u00a0: revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2011.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}